Cancer is a leading cause of cancer-related death. Liver metastases develop in over one-third of patients and are associated with worse prognosis. The evolution in the field of interventional oncology/radiology over the past two decades has expanded image-guided locoregional therapies for colorectal liver metastases (CLM). Historically, hepatic resection was considered the only possible cure for selected patients with CLM. Current evidence supports thermal ablation (TA) as another locally curative treatment modality for small CLM that can be ablated with adequate margins. Other non-thermal ablative treatment options include Yttrium-90 (90Y) radiation segmentectomy (RS), irreversible electroporation (IRE), and histotripsy, with an evolving role in the treatment of CLM. More extensive disease that is not amenable to resection or ablation can be treated with intra-arterial therapies (90Y trans-arterial radioembolization (TARE) and trans-arterial chemoembolization (TACE)). This comprehensive review describes the evolution of interventional oncology treatments for CLM and examines the appropriate indications for each treatment modality.
Keywords: Yttrium-90 radioembolization; chemoembolization; colorectal cancer; interventional oncology; liver metastases; locoregional therapy; margin; thermal ablation.